✦ LIBER ✦

326 Early pharmacokinetics, pharmacodynamics and hepatitis C viral kinetics on treatment with pegylated interferon (IFN) alfa-2A with or without ribavirin: Characterization of the null responder

✍ Scribed by Adrian M. Di Bisceglie; Patricia Osmack; Joyce Hoffman; Janice Strinko

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A randomized trial of pegylated-interfer

✍ A. CIANCIO; A. PICCIOTTO; C. GIORDANINO; A. SMEDILE; M. TABONE; A. MANCA; G. MAR 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 464 KB

P.279 A randomised trial of pegylated in

✍ A. Ciancio; A. Picciotto; C. Giordanino; A. Smedile; M. Tabone; A. Manca; G. Mar 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 138 KB

Effects of pegylated interferon alfa-2b

✍ Steven I. Berk; Alain H. Litwin; Julia H. Arnsten; Evelyn Du; Irene Soloway; Mar 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 697 KB

P.275 Influence of genotype, viral load

✍ H. Cheinquer; M. Pessoa; H. Sette Jr.; E. Parise; R. Paraná; F. Tatsch 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 147 KB

P.276 Influence of genotype, viral load

✍ H. Cheinquer; H. Sette Jr.; M. Pessoa; R. Paraná; E. Parise; F. Tatsch 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 284 KB